This inventor holds 5 USPTO granted patents. Top assignee: Warner-Lambert Company. Active years: 1991-1993.
Company Filing History:
Years Active: 1991-1993
Title: The Innovations of William R. Turner
Introduction
William R. Turner is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial agents and compounds that enhance the effects of cancer treatments. With a total of 5 patents to his name, Turner's work has had a meaningful impact on medical science.
Latest Patents
Turner's latest patents include innovative compounds such as quinolinecarboxylic acid antibacterial agents. These novel 8-alkenyl, alkynyl, allenyl, and cycloalkyl-quinolinecarboxylic acids are described as effective antibacterial agents, along with methods of manufacture that include novel intermediates used in their production. Another significant patent involves substituted dihydroisoquinolinones and related compounds as potentiators. This invention features novel analogs of isoquinolinones and pharmaceutically acceptable salts, along with pharmaceutical compositions and methods for enhancing the lethal effects on tumor cells when treated with DNA damaging agents like ionizing radiation or chemotherapeutic agents.
Career Highlights
William R. Turner has been associated with Warner-Lambert Company, where he has utilized his expertise to drive innovation in pharmaceutical research and development. His work has contributed to advancements in treatments that address critical health issues.
Collaborations
Throughout his career, Turner has collaborated with esteemed colleagues such as Mark J. Suto and John Michael Domagala. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking solutions in the pharmaceutical industry.
Conclusion
William R. Turner is a distinguished inventor whose contributions to the field of pharmaceuticals have led to the development of important antibacterial agents and cancer treatment enhancers. His work continues to influence medical research and improve patient outcomes.